Articles

Pseudo-mutant P53 is a unique phenotype of DNMT3A-mutated pre-leukemia

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel; Department of Hematology, Meir Medical Center, Kfar Saba
Department of Immunology, Weizmann Institute of Science, Rehovot
Department of Immunology, Weizmann Institute of Science, Rehovot, Israel; Department of Pathology, Sackler Faculty of Medicine, Aviv University, Aviv
Department of Immunology, Weizmann Institute of Science, Rehovot
Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot
Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot
Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Medical Oncology and Hematology, University Health Network, Toronto, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot
Department of Immunology, Weizmann Institute of Science, Rehovot
Department of Immunology, Weizmann Institute of Science, Rehovot, Israel; Division of Hematology, Rambam Health Care Campus, Haifa, Israel; Molecular Hematology Clinic, Maccabi Healthcare Services, Aviv
Haematologica Early view Feb 24, 2022 https://doi.org/10.3324/haematol.2021.280329